Numerous cellular clusters across many solid tumors revealed differential expression of TCN2 including non-small cell lung cancer (NSCLC), intrahepatic cholangiocarcinoma (ICC), breast cancer (BC), nasopharyngeal carcinoma (NPC), and skin cutaneous melanoma (SKCM), among others (Figure 4A). Here, TCN2 is linked to intrahepatic cholangiocarcinoma.